Predictors of Medication for Opioid Use Disorder in Treatment Among U.S. Pregnant Women

A recent study featuring PISC Executive Committee Member Zachary Meisel, MD, MPH, MA, and Senior Scholar Eugenia South, MD, MSPH analyzed patterns within medication administration for opioid use disorder and retention treatment among pregnant women. Data was collected from 42,239 treatment episodes across the United States from 2013-2017. Results indicated that, despite current guidelines, medication was administered in only 47.4% of episodes. Retention occurred in 37.8% of medication administered episodes, significantly higher than the 16% retention rate when medications were not administered. Additionally, from 2013-2017, there is a marked increase in medication administration. Notwithstanding, retention rates declined by 6% from 2013-2017. The research team concludes that, despite improvements in medication administration, retention in opioid disorder treatment among pregnant women has fallen short.

Go to Article

Back to News